Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,293,018
+$1,950,371 QoQ
Shares Held
510,325
-1.2% QoQ
Ownership
0.793%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. CGEM ranks #122 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,293,018 510,325
2026-03-31 $7,342,647 516,724
2025-12-31 $3,584,276 346,307
2025-09-30 $3,304,128 557,189
2025-06-30 $4,979,475 661,285
2025-03-31 $3,969,594 524,385
2024-12-31 $1,891,188 155,270
2024-09-30 $6,859,934 409,793
2024-06-30 $7,198,272 412,745
2024-03-31 $2,238,186 131,349
2023-12-31 $1,379,848 135,412
2023-09-30 $935,018 103,317
2023-06-30 $212,916 19,788
2023-03-31 $881,834 86,201
2022-12-31 $736,695 69,829
2022-09-30 $806,364 62,899
2022-06-30 $367,574 28,672
2022-03-31 $475,683 45,433
2021-12-31 $448,226 29,049
2021-09-30 $209,088 9,264
2021-06-30 $376,876 14,636
2021-03-31 $972,369 23,335